Is Neurogene Inc. (NGNE) a Buy, Sell, or Hold?
Neurogene Inc.
NASDAQ:NGNE
$39.45 USD
$0.37 (0.95%)
- Volume
- 181.59K
- Average Volume
- 210.89K
- Market Capitalization
- $623.4M
- P/E Ratio
- -7.84
- Dividend Yield
- 0.00%
- Price Target
- $70.00
- Year High
- $43.66
- Year Low
- $15.93
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.08
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
19
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
18
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 48377
NGNE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
NGNE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-07-06 | S-Sale | 36.021 | 2026-07-07 |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-07-07 | S-Sale | 36.134 | 2026-07-07 |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-07-01 | S-Sale | 34.059 | 2026-07-02 |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-07-02 | S-Sale | 34.579 | 2026-07-02 |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-07-02 | S-Sale | 35.227 | 2026-07-02 |
| Woods Keith | director | 2024-01-16 | A-Award | 32.3 | 2026-06-16 |
| Woods Keith | director | 2024-06-14 | A-Award | 42.59 | 2026-06-16 |
| Woods Keith | director | 2025-06-12 | A-Award | 20.4 | 2026-06-16 |
| Woods Keith | director: | 2023-12-18 | 0 | 2026-06-16 | |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-05-06 | S-Sale | 30.0732 | 2026-05-08 |
| Cvijic Christine Mikail | director, officer: President and CFO | 2026-05-06 | S-Sale | 32.4358 | 2026-05-08 |
| Shafer Christina | officer: Chief Commercial Officer | 2026-05-05 | A-Award | 28.94 | 2026-05-07 |
| Shafer Christina | officer | 2026-04-20 | 0 | 2026-04-20 | |
| Cvijic Christine Mikail | officer: President and CFO | 2026-03-26 | S-Sale | 21.6247 | 2026-03-30 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2026-03-26 | S-Sale | 22.0749 | 2026-03-30 |
| Jordan Julie | officer: Chief Medical Officer | 2026-03-26 | S-Sale | 21.8932 | 2026-03-30 |
| Cobb Stuart | officer: Chief Scientific Officer | 2026-03-13 | S-Sale | 20.41 | 2026-03-17 |
| Cobb Stuart | officer: Chief Scientific Officer | 2026-03-13 | S-Sale | 21.34 | 2026-03-17 |
| Cobb Stuart | officer: Chief Scientific Officer | 2026-03-13 | S-Sale | 22.08 | 2026-03-17 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-03-13 | S-Sale | 20.4224 | 2026-03-17 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-03-13 | S-Sale | 21.2451 | 2026-03-17 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-03-13 | S-Sale | 22.0195 | 2026-03-17 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-02-27 | S-Sale | 25.1096 | 2026-03-03 |
| Cobb Stuart | officer: Chief Scientific Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| Jordan Julie | officer: Chief Medical Officer | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| Jordan Julie | officer: Chief Medical Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| Cvijic Christine Mikail | officer: President and CFO | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2026-02-20 | A-Award | 0 | 2026-02-24 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| PALEKAR ROHAN | director | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| BAFFI ROBERT | director | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| Noonberg Sarah B. | director | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| Freedland Cory S. | director | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| Woods Keith | director | 2026-02-20 | A-Award | 17.64 | 2026-02-24 |
| BAFFI ROBERT | director | 2025-06-12 | A-Award | 20.4 | 2025-06-13 |
| Woods Robert Keith | director | 2025-06-12 | A-Award | 20.4 | 2025-06-13 |
| PALEKAR ROHAN | director | 2025-06-12 | A-Award | 20.4 | 2025-06-13 |
| Freedland Cory S. | director | 2025-06-12 | A-Award | 20.4 | 2025-06-13 |
| Noonberg Sarah B. | director | 2025-06-12 | A-Award | 20.4 | 2025-06-13 |
| Cobb Stuart | officer: Chief Scientific Officer | 2025-05-14 | S-Sale | 15.1542 | 2025-05-15 |
| Cobb Stuart | officer: Chief Scientific Officer | 2025-03-26 | A-Award | 16.14 | 2025-03-28 |
| Cobb Stuart | officer: Chief Scientific Officer | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| Cvijic Christine Mikail | officer: President and CFO | 2025-03-26 | A-Award | 16.14 | 2025-03-28 |
| Cvijic Christine Mikail | officer: President and CFO | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| Jordan Julie | officer: Chief Medical Officer | 2025-03-26 | A-Award | 16.14 | 2025-03-28 |
| Jordan Julie | officer: Chief Medical Officer | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2025-03-26 | A-Award | 16.14 | 2025-03-28 |
| Cvijic Christine Mikail | officer: President and CFO | 2025-03-13 | S-Sale | 16.94 | 2025-03-17 |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-26 | P-Purchase | 27.5 | 2024-11-27 |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-26 | P-Purchase | 26.73 | 2024-11-27 |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-26 | P-Purchase | 26.01 | 2024-11-27 |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-26 | P-Purchase | 24.91 | 2024-11-27 |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-25 | 0 | 2024-11-27 | |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-25 | 0.001 | 2024-11-27 | |
| Samsara BioCapital GP, LLC | 10 percent owner | 2024-11-25 | 0 | 2024-11-27 | |
| Cvijic Christine Mikail | officer: President and CFO | 2024-11-22 | P-Purchase | 20.475 | 2024-11-25 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2024-11-22 | P-Purchase | 20.4 | 2024-11-25 |
| Woods Robert Keith | director | 2024-06-14 | A-Award | 42.59 | 2024-06-17 |
| PALEKAR ROHAN | director | 2024-06-14 | A-Award | 42.59 | 2024-06-17 |
| BAFFI ROBERT | director | 2024-06-14 | A-Award | 42.59 | 2024-06-17 |
| Noonberg Sarah B. | director | 2024-06-14 | A-Award | 42.59 | 2024-06-17 |
| Freedland Cory S. | director | 2024-06-14 | A-Award | 42.59 | 2024-06-17 |
| McMinn Rachel | director, officer: Chief Executive Officer | 2024-03-13 | A-Award | 36.06 | 2024-03-14 |
| Cvijic Christine Mikail | officer: President and CFO | 2024-03-13 | A-Award | 36.06 | 2024-03-14 |
| Cvijic Christine Mikail | officer: President and CFO | 2024-03-13 | A-Award | 0 | 2024-03-14 |
| Cobb Stuart | officer: Chief Scientific Officer | 2024-03-13 | A-Award | 36.06 | 2024-03-14 |
| Cobb Stuart | officer: Chief Scientific Officer | 2024-03-13 | A-Award | 0 | 2024-03-14 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| BAKER BROS. ADVISORS LP | director, other: Former 10% Owner | 2023-12-18 | A-Award | 0 | 2023-12-20 |